Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CHINA-BIOTICS, INC | v315639_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - CHINA-BIOTICS, INC | v315639_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - CHINA-BIOTICS, INC | v315639_ex32-2.htm |
| EX-21.1 - EXHIBIT 21.1 - CHINA-BIOTICS, INC | v315639_ex21-1.htm |
| EX-31.1 - EXHIBIT 31.1 - CHINA-BIOTICS, INC | v315639_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - CHINA-BIOTICS, INC | v315639_ex32-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CHINA-BIOTICS, INC | Financial_Report.xls |
Exhibit 16.3
Securities and Exchange Commission
100 F Street N.E.
Washington, DC 20549
| Re: | Form 10-K of China-Biotics, Inc. (the “Company”) for the fiscal year ended March 31, 2012 |
Dear Sir or Madam:
We have been furnished with a copy of the disclosure about the Due Diligence Report contained in Item 9 of the Company’s above-referenced filing. We agree with the statements made in that Item about the Due Diligence Report.
Sincerely yours,
/s/ Thornhill Capital LLC
Thornhill Capital LLC